Neos to sell up to $73.6 million shares at $14.00-$16.00 each in IPO

Deal includes 30-day greenshoe option for another 600,000 shares

By Susanna Moon

Chicago, July 13 – Neos Therapeutics, Inc. registered to sell up to $73.6 million common shares in its initial public offering at a price between $14.00 and $16.00 per share, according to a Form S-1 filed Friday with the Securities and Exchange Commission. The deal includes a 30-day over-allotment option for another 600,000 shares.

The company plans to sell up to 4 million shares.

UBS Securities LLC, BMO Capital Markets Corp. and RBC Capital Markets, LLC are the joint bookrunning managers. JMP Securities LLC also is an underwriter.

Neos has applied to list the common stock on the Nasdaq under the symbol “NEOS.”

The deal was announced June 19.

As previously announced, proceeds will be used for pre-commercialization planning, commercialization, working capital, capital expenditures and general corporate purposes.

The pharmaceutical company is based in Grand Prairie, Texas.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.